UBS Asset Management Americas Inc. grew its holdings in Cooper Companies Inc (NYSE:COO) by 12.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 558,683 shares of the medical device company’s stock after buying an additional 59,857 shares during the quarter. UBS Asset Management Americas Inc. owned approximately 1.14% of Cooper Companies worth $121,726,000 at the end of the most recent reporting period.
Several other large investors have also made changes to their positions in COO. Advisory Services Network LLC increased its stake in shares of Cooper Companies by 30.6% in the second quarter. Advisory Services Network LLC now owns 457 shares of the medical device company’s stock valued at $109,000 after buying an additional 107 shares in the last quarter. Canada Pension Plan Investment Board acquired a new stake in shares of Cooper Companies in the third quarter valued at $163,000. FNY Managed Accounts LLC acquired a new stake in shares of Cooper Companies in the fourth quarter valued at $217,000. CAPROCK Group Inc. acquired a new stake in shares of Cooper Companies in the fourth quarter valued at $222,000. Finally, Ballentine Partners LLC acquired a new stake in shares of Cooper Companies in the third quarter valued at $223,000. Institutional investors own 98.55% of the company’s stock.
In other news, EVP Carol R. Kaufman sold 13,362 shares of Cooper Companies stock in a transaction dated Monday, March 12th. The stock was sold at an average price of $243.88, for a total transaction of $3,258,724.56. Following the transaction, the executive vice president now owns 59,305 shares in the company, valued at approximately $14,463,303.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Allan E. Rubenstein sold 500 shares of Cooper Companies stock in a transaction dated Wednesday, December 27th. The shares were sold at an average price of $222.00, for a total value of $111,000.00. Following the transaction, the director now owns 6,590 shares in the company, valued at approximately $1,462,980. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 104,516 shares of company stock worth $24,459,155. Company insiders own 1.60% of the company’s stock.
Cooper Companies (NYSE:COO) last issued its earnings results on Thursday, March 8th. The medical device company reported $2.79 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.51 by $0.28. Cooper Companies had a return on equity of 16.90% and a net margin of 7.83%. The firm had revenue of $590.00 million for the quarter, compared to analysts’ expectations of $583.07 million. During the same quarter last year, the business earned $1.93 earnings per share. The company’s revenue was up 18.2% compared to the same quarter last year. equities analysts expect that Cooper Companies Inc will post 11.83 earnings per share for the current fiscal year.
A number of analysts have recently weighed in on COO shares. Stifel Nicolaus restated a “buy” rating and issued a $265.00 target price (down from $275.00) on shares of Cooper Companies in a research note on Friday, December 8th. Cleveland Research lowered Cooper Companies from a “buy” rating to a “hold” rating in a research report on Friday, February 9th. Jefferies Group reiterated a “buy” rating and issued a $285.00 price objective on shares of Cooper Companies in a research report on Friday, March 9th. Stephens reiterated a “hold” rating and issued a $270.00 price objective on shares of Cooper Companies in a research report on Friday, March 9th. Finally, Oppenheimer set a $250.00 price objective on Cooper Companies and gave the stock a “hold” rating in a research report on Friday, December 8th. Eight investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of $267.50.
ILLEGAL ACTIVITY NOTICE: This report was originally reported by BBNS and is owned by of BBNS. If you are reading this report on another website, it was stolen and reposted in violation of U.S. & international copyright and trademark legislation. The correct version of this report can be accessed at https://baseballnewssource.com/2018/03/14/ubs-asset-management-americas-inc-raises-stake-in-cooper-companies-inc-coo/1890555.html.
Cooper Companies Company Profile
The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.